VB Impact on Orthopedics
VB Experience		Original Company	Current Company
Placement Agents of the 1st IPO of a Bone Graft Substitute (BONZ) Company
Introduced 1st & Only US Mobile Bearing Ankle Arthroplasty
Built the 1st Company to Define & Focus on the Small Bone & Joint Arthroplasty Industry.
Developed the #1 Cervical & Lumbar Disc Replacements (Prodisc L & C)1
Founded the #1 Market Share Re-processor of Single Use Disposable Devices
Created the #1 Spinal Stenosis Technology1
Acquired Leading Integrated Interbody Fusion Products
Strategic Advisor to Bristol Myers Squibb 2: The #1 Pharmaceutical Company Divestiture of Orthopedic Division  Strategic Adviser & Consultant to the J&J World Franchise Counsel on the DePuy Acquisition. Strategic Adviser to Olympus on Stryker OP-I Acquisition
Since Inception [2004], Musculoskeletal Clinical Regulatory Advisers, LLC has Contracted Approximately >270 Clients to Date.
The MCRA team has achieved: 1,000 510(k) Submissions & Approvals 75 Investigational Device Exemptions (IDE) 14 Pre-Marketing Approvals (PMA) Executed or developed >730 Health Economics, Reimbursement, Public Policy and related strategies.		>400 Patents have been granted and >240 Trademarks were registered by the United States Patent and Trademark Office Performed >210 Audits for Notified Body (TÜV Product Service) to ISO 9001 / ISO 13485 Including Numerous Audits at Leading Orthopedic Companies
Key Opinion Leadership:
• Spine Arthroplasty • Nucleus Arthroplasty • Ankle Arthroplasty	• Interspinous / Interlaminar Spine • Non-Fusion Technology • Stand-Alone Integrated Interbody • Spine Fusion • Small Bone & Joint		• Finger Joint Arthroplasty • Thumb Arthroplasty • Wrist Arthroplasty
1 VB defines #1 as unit volume or sales volume. 2 Two of the principals acted as strategic advisers to Bristol Myers Squibb on the divestiture of Zimmer.